Curis, Inc
Edit Page
Report
Scan day: 12 February 2014 UTC
1
Virus safety - good
Description: Developing small molecule and peptide drugs in regulatory signaling and regenerative pathways. Introduces technical background, product pipeline, collaborations, investment data and careers headquartered from Cambridge, Massachusetts. (Nasdaq: CVGP)
Curis - Controling regeneration signaling pathways to restore human health
Size: 74 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
| Page title: | Curis - Controling regeneration signaling pathways to restore human health |
| Keywords: | CRIS, Curis, biotechnology, drug development, Genentech, Amylin, Ortho Biotech, Johnson and Johnson, ESI, stem cells, pharmaceutical, cancer, chemotherapy, anemia, hepatitis, dialysis, neuroscience, hematopoiesis, inflammation, molecular biology, cellular biology, Hedgehog, Hh, BMP, CUR-61614, sonic hedge hog, bmp7, kidney disease, neurological disorders, cancer, alopecia, biotech, biotechnology, genomics, genetic engineering, medicines, biopharmaceuticals, human pharmaceuticals |
| Description: | Curis is a therapeutic drug development company, focusing on regulatory pathways that control repair and regeneration using proteins or small molecules to modulate these pathways. |
| IP-address: | 216.92.11.85 |
WHOIS Info
| NS | Name Server: NS1.EARTHLINKBUSINESS.COM Name Server: NS2.EARTHLINKBUSINESS.COM Name Server: NS3.EARTHLINKBUSINESS.COM |
| WHOIS | Status: clientTransferProhibited |
| Date | Creation Date: 13-mar-1997 Expiration Date: 14-mar-2016 |